Advertisement

Inpharma Weekly

, Volume 1574, Issue 1, pp 9–10 | Cite as

Alemtuzumab superior to chlorambucil for front-line CLL therapy

Meeting report
  • 3 Downloads

Keywords

Chronic Lymphocytic Leukaemia Alemtuzumab Chlorambucil Chronic Lymphocytic Leukaemia Patient Famciclovir 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2007

Personalised recommendations